Biopharma SHAKTI Gets a Strong Start With 25 Trial Sites
Biopharma SHAKTI gets a 25-site clinical trial pilot as NIPER Raebareli and AstraZeneca India sign an MoU. What the pilot tests and what is undisclosed.
Biopharma SHAKTI gets a 25-site clinical trial pilot as NIPER Raebareli and AstraZeneca India sign an MoU. What the pilot tests and what is undisclosed.